Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Document Type
Year range
1.
Yakugaku Zasshi ; 142(6): 601-609, 2022.
Article in Japanese | MEDLINE | ID: covidwho-1869127

ABSTRACT

The fight against coronavirus disease 2019 (COVID-19) in Japan began after January 2020. In order for the country to resume an active social life as a society, it is necessary to prevent an increase in the number of newly infected people with severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), and to prevent aggravation and/or death after infection. Although several therapeutic agents have been developed to treat COVID-19 after infection, vaccination with SARS-CoV-2 is the most effective in controlling or even ending the COVID-19 pandemic in Japan. The Ministry of Health, Labour and Welfare has convened a council to publish the collected data on COVID-19 and to proceed with discussions for promoting safe and effective vaccination. However, no matter how we release to the public the scientific basis of our findings and proposed methods of prevention and treatment, there remain cases where false opinions have spread, and vaccinations are refused accordingly. This paper traces the course of the work of this council, and considers current challenges in communicating COVID-19 information to the public based on scientific evidence.


Subject(s)
COVID-19 , SARS-CoV-2 , COVID-19/prevention & control , Humans , Japan/epidemiology , Pandemics , Vaccination
2.
Hum Vaccin Immunother ; 18(5): 2031775, 2022 11 30.
Article in English | MEDLINE | ID: covidwho-1774279

ABSTRACT

AIM: To understand the awareness of the willingness to be vaccinated and influencing factors of the new coronavirus vaccine (neo-crown vaccine) among medical personnel in North China and to provide a theoretical basis and application guidelines for the feasibility of coronavirus vaccination by medical personnel to guide the public to actively be vaccinated by taking initiative and obtaining a coronavirus vaccination as soon as possible. METHODS: From April 2021 to June 2021, medical staff in North China were selected to complete an online questionnaire survey using Questionnaire Star to analyze the willingness rate to be vaccinated with the new coronavirus vaccine, and the influencing factors were analyzed using binary logistic regression. RESULTS: Among 621 respondents, 85.7% were willing to be vaccinated after the launch of the new vaccine. In the questionnaire, respondents were asked to answer questions such as "Do you think it is better to receive as few vaccines as possible at the same time?," "If I get the new coronavirus vaccine, I may have serious side effects.," "The new coronavirus vaccine is safe.," "Specifically, for the new coronavirus vaccine, do you think it is safe?," and "Specifically, for the new coronavirus vaccine, do you think it is easy to administer?." These beliefs have an important influence on the vaccination of medical staff with the new coronavirus vaccine in Northern China (OR = 1.610,95% CI: 1.055 ~ 2.456; OR = 1.715,95% CI: 1.164 ~ 2.526; OR = 0.401, 95% CI: 0.212 ~ 0.760; OR = 0.352,95% CI: 0.147 ~ 0.843; OR = 3.688,95% CI: 1.281 ~ 10.502, respectively; All P values < .05). CONCLUSIONS: Medical staff have a high willingness to be vaccinated with the new coronavirus vaccine, which plays a positive role in the publicity of the vaccine.


Subject(s)
COVID-19 Vaccines , COVID-19 , COVID-19/prevention & control , China , Humans , SARS-CoV-2 , Vaccination
SELECTION OF CITATIONS
SEARCH DETAIL